Study: 11C-acetate-PET/CT IDs lymph-node metastasis in prostate cancer

05/6/2013 | AuntMinnie.com (free registration)

PET/CT imaging with carbon-11 acetate is useful for identification of lymphatic metastasis in patients making plans for or completing radical prostatectomy, according to a study published in The Journal of Nuclear Medicine that involved 107 prostate cancer patients who had intermediate- or high-risk localized disease. The study found that 11C-acetate-PET/CT detected pelvic lymph-node or distant metastasis in 36 patients, while histopathological results found lymph-node metastasis in 25 patients. Treatment-failure-free survival was poorer among those with positive PET scans, researchers said. The results show that "PET may have demonstrated nodal disease not removed surgically or identified pathologically," they wrote.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park